1. Home
  2. BLZE vs OMER Comparison

BLZE vs OMER Comparison

Compare BLZE & OMER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLZE
  • OMER
  • Stock Information
  • Founded
  • BLZE 2007
  • OMER 1994
  • Country
  • BLZE United States
  • OMER United States
  • Employees
  • BLZE N/A
  • OMER N/A
  • Industry
  • BLZE Computer Software: Prepackaged Software
  • OMER Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLZE Technology
  • OMER Health Care
  • Exchange
  • BLZE Nasdaq
  • OMER Nasdaq
  • Market Cap
  • BLZE 300.7M
  • OMER 304.9M
  • IPO Year
  • BLZE 2021
  • OMER 2009
  • Fundamental
  • Price
  • BLZE $9.45
  • OMER $4.15
  • Analyst Decision
  • BLZE Strong Buy
  • OMER Strong Buy
  • Analyst Count
  • BLZE 7
  • OMER 5
  • Target Price
  • BLZE $10.21
  • OMER $18.00
  • AVG Volume (30 Days)
  • BLZE 749.1K
  • OMER 931.1K
  • Earning Date
  • BLZE 11-06-2025
  • OMER 11-12-2025
  • Dividend Yield
  • BLZE N/A
  • OMER N/A
  • EPS Growth
  • BLZE N/A
  • OMER N/A
  • EPS
  • BLZE N/A
  • OMER N/A
  • Revenue
  • BLZE $137,286,000.00
  • OMER N/A
  • Revenue This Year
  • BLZE $16.78
  • OMER N/A
  • Revenue Next Year
  • BLZE $13.98
  • OMER $9,040.39
  • P/E Ratio
  • BLZE N/A
  • OMER N/A
  • Revenue Growth
  • BLZE 19.08
  • OMER N/A
  • 52 Week Low
  • BLZE $3.94
  • OMER $2.95
  • 52 Week High
  • BLZE $9.92
  • OMER $13.60
  • Technical
  • Relative Strength Index (RSI)
  • BLZE 74.51
  • OMER 49.82
  • Support Level
  • BLZE $7.91
  • OMER $4.07
  • Resistance Level
  • BLZE $9.92
  • OMER $4.34
  • Average True Range (ATR)
  • BLZE 0.41
  • OMER 0.18
  • MACD
  • BLZE 0.05
  • OMER -0.03
  • Stochastic Oscillator
  • BLZE 76.69
  • OMER 15.69

About BLZE Backblaze Inc.

Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage, which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and Other regions.

About OMER Omeros Corporation

Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.

Share on Social Networks: